Pharmasyntez, the Russian company, has been given a “compulsory license” to make the drug for one year without the permission of Gilead. “The government said in a decree at the time that the move was in the interests of Russia’s own security,” according to the article. “According to the decree, Russia had to pay compensation to the drug’s patent-holder. The amount was not specified.”
Estimated reading time: 0 minutes, 31 seconds
Russian Supreme Court Denies Gilead’s Patent Lawsuit Over Anti-COVID Drug
Russia’s Supreme Court rejected a lawsuit filed by Gilead Sciences, a U.S. biotech firm, after the Russian government allowed another company to produce Gilead’s anti-COVID-19 drug named remdesivir. So reports Reuters.
Latest from Progressive Law Practice
- California Drivers No Longer Need To Answer Cop’s Question
- Iowa Ban On LGBTQ+ Books Largely Blocked Ahead Of Enactment
- Michael Cohen's Legal Defense Included Non-existent Cases Invented By Google Bard: Report
- Hershey Sued For False Advertising Over 'Cute' Holiday Candy
- Terms Of Bombshell Google Privacy Settlement Undisclosed
Most Read
-
-
Apr 07 2013
-
Written by PLP News
In a sensational case that has reportedly “grabbed the attention…
-
-
-
Mar 31 2013
-
Written by PLP News
A DLA Piper associate’s e-mail stating “that bill shall know…
-
-
-
Jan 26 2014
-
Written by PLP News
A 55-year-old attorney at White & Case, who recently filed…
-
-
-
Jun 15 2014
-
Written by Tami Kamin Meyer
More than 1.2 million applications, or “apps,” are available at…
-